Xiong Xin, Rong Rong, Tang Li-Ying, Sun Tie, Pan Yi-Cong, Shu Hui-Ye, Zhang Li-Juan, Ge Qian-Min, Liang Rong-Bin, Shao Yi
Department of Pathology and Ophthalmology, The First Affiliated Hospital of Nanchang University, Jiangxi Centre of Natural Ocular Disease Clinical Research Center, Nanchang, Jiangxi, 330006, People's Republic of China.
Eye Center of Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China.
Cancer Manag Res. 2022 Dec 5;14:3405-3415. doi: 10.2147/CMAR.S363115. eCollection 2022.
To explore the risk factors of ocular metastasis (OM) in patients with hepatocellular carcinoma (HCC) by analyzing the demographic characteristics and serum markers.
From July 2002 to December 2012, 1064 HCC patients were included in our study. The chi-squared test and Student's -test were used to assess the difference between OM and any other metastasis (NOM). Receiver operating curve (ROC) was used to analyze the diagnostic value of serum biomarkers in HCC patients with OM.
The incidence of OM in HCC patients was 1.88% in our research. There are no significant differences in age, gender, or histopathology in the OM group and the group without any metastasis. Binary logistic regression analysis presented that compared with the patients without cancer metastasis, carbohydrate antigen 125 (CA-125) and hemoglobin (Hb) were risk factors in hepatocellular carcinoma patients with OM (P < 0.05). The ROC curve analysis showed that the areas under the CA-125, Hb, and CA125+Hb curves were 0.877, 0.554, and 0.431, and the cutoff values of CA-125 and Hb each were 115.78 u/mL and 120.50 g/L.
Our data suggest that CA-125 and Hb are risk indicators in hepatocellular carcinoma patients with OM, and that CA-125+Hb has potentially greater utility in diagnosing hepatocellular carcinoma.
通过分析人口统计学特征和血清标志物,探讨肝细胞癌(HCC)患者发生眼部转移(OM)的危险因素。
2002年7月至2012年12月,1064例HCC患者纳入本研究。采用卡方检验和t检验评估OM组与其他任何转移(NOM)组之间的差异。采用受试者工作特征曲线(ROC)分析血清生物标志物在HCC合并OM患者中的诊断价值。
本研究中HCC患者OM的发生率为1.88%。OM组与无任何转移组在年龄、性别或组织病理学方面无显著差异。二元逻辑回归分析显示,与无癌转移患者相比,糖类抗原125(CA-125)和血红蛋白(Hb)是HCC合并OM患者的危险因素(P<0.05)。ROC曲线分析显示,CA-125、Hb以及CA125+Hb曲线下面积分别为0.877、0.554和0.431,CA-125和Hb的截断值分别为115.78 u/mL和120.50 g/L。
我们的数据表明,CA-125和Hb是HCC合并OM患者的风险指标,且CA-125+Hb在诊断HCC方面可能具有更大的效用。